Aspirin and lipid-lowering agents reduce cardiovascular events following CABG, but there is little evidence about other therapies. Commentary
- PMID: 16380016
- DOI: 10.1016/j.ebcm.2005.03.022
Aspirin and lipid-lowering agents reduce cardiovascular events following CABG, but there is little evidence about other therapies. Commentary
Comment on
-
Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials.J Am Coll Cardiol. 2005 Jan 18;45(2):177-84. doi: 10.1016/j.jacc.2004.09.065. J Am Coll Cardiol. 2005. PMID: 15653013 Review.
Similar articles
-
Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction.Circulation. 2003 Sep 9;108 Suppl 1:II24-8. doi: 10.1161/01.cir.0000087654.26917.00. Circulation. 2003. PMID: 12970203
-
The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.Am Heart J. 2013 Aug;166(2):282-289.e1. doi: 10.1016/j.ahj.2013.04.011. Epub 2013 Jun 15. Am Heart J. 2013. PMID: 23895811
-
Secondary prevention after coronary artery bypass graft surgery: a primer.Curr Opin Cardiol. 2016 Nov;31(6):635-643. doi: 10.1097/HCO.0000000000000331. Curr Opin Cardiol. 2016. PMID: 27583372 Review.
-
Lipid-lowering drug use and cardiovascular events after myocardial infarction.Ann Pharmacother. 2002 May;36(5):751-7. doi: 10.1345/aph.1A308. Ann Pharmacother. 2002. PMID: 11978147
-
Drug treatment of hyperlipidemia in women.JAMA. 2004 May 12;291(18):2243-52. doi: 10.1001/jama.291.18.2243. JAMA. 2004. PMID: 15138247 Review.
Publication types
LinkOut - more resources
Full Text Sources